• Accueil >
  • Publications >
  • MBD4 deficiency is predictive of response to immune checkpoint inhibitors in metastatic uveal melanoma patients

MBD4 deficiency is predictive of response to immune checkpoint inhibitors in metastatic uveal melanoma patients

1 sept. 2022European Journal of Cancer

DOI : 10.1016/j.ejca.2022.06.033

Auteurs

Mathilde Saint-Ghislain, Anne-Céline Derrien, Lionnel Geoffrois, Lauris Gastaud, Thierry Lesimple, Sylvie Negrier, Nicolas Penel, Jean-Emmanuel Kurtz, Yannick Le Corre, Caroline Dutriaux, Sophie Gardrat, Raymond Barnhill, Alexandre Matet, Nathalie Cassoux, Alexandre Houy, Toulsie Ramtohul, Vincent Servois, Pascale Mariani, Sophie Piperno-Neumann, Marc-Henri Stern, Manuel Rodrigues

Membres